Skip to main content
. 2022 Feb 28;13:843539. doi: 10.3389/fendo.2022.843539

Table 6.

Equivalence tests (TOST procedure) of the estimated effect sizes in Table 4 .

EE Heart Rate Cardiac Output Stroke Volume Systemic Vascular Resistance
LB=-0.1 UB=0.1 LB=-5 UB =5 LB= -1 UB=1 LB=-10 UB=10 LB= -500 UB=500
Dose [LT3] 0.004 0.003 0.000 0.004 0.002 0.011 0.038 0.018 0.023 0.002
Dose [LT4] 0.004 0.002 0.000 0.005 0.003 0.005 0.074 0.008 0.009 0.004
Time 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Time2 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Dose [LT3] * Time 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Dose [LT4] * Time 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Dose [LT3] * Time2 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Dose [LT4] * Time2 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000

LB, lower bound; UB, upper bound. Two one-sided t-tests were conducted for each estimated fixed effects of the models presented in Table 4 . P-values presented in this table indicate the significance of the TOST procedure, p-values < 0.05 indicate that null hypothesis that a fixed effect does not fall in the region of [LB, UB] are rejected, and we thus accept the alternative hypothesis that the fixed effect is zero.